Neoadjuvant therapy with anlotinib in a 5-year-old child with advanced papillary thyroid carcinoma: a case report - Poll - MDSpire

Neoadjuvant therapy with anlotinib in a 5-year-old child with advanced papillary thyroid carcinoma: a case report

  • By

  • Yuan Gong

  • Hongjiang Ma

  • Mingyang Lu

  • Qiuyu Meng

  • Bin Liu

  • Tingting Yang

  • Haifeng Ma

  • Yanjun Su

  • Ruochuan Cheng

  • May 13, 2026

  • 0 min

Share

Original Source(s)

Neoadjuvant therapy with anlotinib in a 5-year-old child with advanced papillary thyroid carcinoma: a case report

  • by Yuan Gong, Hongjiang Ma, Mingyang Lu, Qiuyu Meng, Bin Liu, Tingting Yang, Haifeng Ma, Yanjun Su, Ruochuan Cheng

  • May 13, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

FOXA2 in cancer: from fundamental biology to clinical translation